ClinicalTrials.gov: First posted in the last 14 days

Conditions: Alcohol Use Disorder; Sexually Transmitted Diseases
Interventions: Drug: Standardized kudzu; Other: Placebo
Sponsors: University of California, San Francisco; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting

Condition: Cholecystitis; Acute, Choledocholithiasis
Intervention: Diagnostic Test: magnetic resonance cholangiopancreatography (MRCP)
Sponsors: Perspectum Diagnostics Ltd; Oxford University Hospitals NHS Trust
Not yet recruiting

Conditions: Chronic Myeloid Leukemia; Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Intervention: Drug: Ponatinib
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Recruiting

Conditions: Breastfeeding; Postpartum Depression
Intervention: Other: Pacifier
Sponsors: University of California, Davis; Benedictine University; Yale University
Not yet recruiting

Condition: Genetic Condition
Interventions: Diagnostic Test: IVF combined with PGT-A; Diagnostic Test: ICSI combined with PGT-A
Sponsor: IVI Middle East Fertility Clinic
Not yet recruiting

Condition: Women With Suspected Breast Lesion
Intervention: Diagnostic Test: mammography
Sponsors: Beijing Cancer Hospital; Peking University
Recruiting

Condition: Mucopolysaccharidosis II
Intervention: Drug: JR-141
Sponsor: JCR Pharmaceuticals Co., Ltd.
Not yet recruiting

Condition: Polyps
Intervention:
Sponsor: Zhejiang University
Recruiting

Conditions: Glucose Intolerance; Glucose, Low Blood; Glucose, High Blood
Intervention: Dietary Supplement: artificial sweeteners
Sponsor: Weizmann Institute of Science
Enrolling by invitation

Condition: Degeneration Disc Intervertebral
Interventions: Drug: Abaloparatide; Drug: Placebo
Sponsor: Johns Hopkins University
Not yet recruiting

Conditions: Craniopharyngioma; Hypothalamic Obesity; Metabolic Syndrome
Intervention: Device: Hypothalamic Deep Brain Stimulation
Sponsor: University of British Columbia
Withdrawn

Condition: Cushing's Disease
Intervention: Drug: LCI699
Sponsor: Novartis Pharmaceuticals
Not yet recruiting

Conditions: Hyperglycaemia (Diabetic); Hyperlipidemias
Interventions: Drug: Low dose omega-3 fatty acid supplementation; Drug: High dose omega-3 fatty acid supplementation; Drug: Control drug
Sponsor: Zhejiang University
Recruiting

Conditions: Abdominal Pain; Shoulder Pain; Satisfaction; Complication
Intervention:
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Recruiting

Condition: HIV Infection
Intervention: Drug: maraviroc (300 mg QD) + atazanavir/ritonavir (300 and 200 mg /100 mg QD)
Sponsor: University of Turin, Italy
Withdrawn

Conditions: Parenting; Parent-Child Relations
Intervention:
Sponsor: Child Development Resources
Recruiting

Conditions: Cancer (Colon Cancer, Breast Cancer, Lymphoma, Multiple Myeloma); Elderly; Antineoplastic Agents; Cardiotoxicity
Interventions: Other: Intensive cardiovascular monitoring; Other: No intervention
Sponsors: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; IBSAL-Instituto de Investigación Biomédica de Salamanca, Fundación IECSCYL-IBSAL; Instituto de Salud Carlos III
Not yet recruiting

Condition: Autism Spectrum Disorder
Intervention: Behavioral: Access to services via peer coaching
Sponsors: Health Resources and Services Administration (HRSA); University of Rochester; University of Pennsylvania; University of California, Davis; Drexel University
Recruiting

Condition: Depression
Interventions: Other: Basic implementation package; Other: Enhanced implementation package
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH); Ministry of Health, Malawi; University of Malawi College of Medicine
Not yet recruiting

Conditions: Osteoarthritis; Osteoarthritis, Knee; Osteoarthritis, Hip; Osteoarthritis Ankle
Intervention: Other: Group Physical Therapy Classes
Sponsor: University of Missouri-Columbia
Not yet recruiting

Latest Images